in 2017, while Mounjaro, Ozempics primary competitor, was approved in 2022
(The FDA has received more than 700 adverse event reports tied to compounded GLP-1s, but its not clear if the events were caused by the drugs.) The companies also see compounders as a threat to their obesity drug sales, which are estimated to balloon to $100 billion a year by 2030
Supports detoxification and overall skin health
For the broader picture of which peptides already have FDA approval, see our FDA Approved Peptides List 2026
Furthermore, vitamin C is known to have a protective effect against inflammation, oxidative stress, and certain neurochemical factors and neurotransmitters, which are implicated in the pathophysiology of ADHD (85, 86)